Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Intervalo de año de publicación
1.
J Physiol Sci ; 74(1): 33, 2024 Jun 12.
Artículo en Inglés | MEDLINE | ID: mdl-38867187

RESUMEN

Hibernation and torpor are not passive responses caused by external temperature drops and fasting but are active brain functions that lower body temperature. A population of neurons in the preoptic area was recently identified as such active torpor-regulating neurons. We hypothesized that the other hypothermia-inducing maneuvers would also activate these neurons. To test our hypothesis, we first refined the previous observations, examined the brain regions explicitly activated during the falling phase of body temperature using c-Fos expression, and confirmed the preoptic area. Next, we observed long-lasting hypothermia by reactivating torpor-tagged Gq-expressing neurons using the activity tagging and DREADD systems. Finally, we found that about 40-60% of torpor-tagged neurons were activated by succeeding isoflurane anesthesia and by icv administration of an adenosine A1 agonist. Isoflurane-induced and central adenosine-induced hypothermia is, at least in part, an active process mediated by the torpor-regulating neurons in the preoptic area.


Asunto(s)
Adenosina , Isoflurano , Neuronas , Área Preóptica , Animales , Área Preóptica/efectos de los fármacos , Área Preóptica/metabolismo , Isoflurano/farmacología , Isoflurano/administración & dosificación , Adenosina/administración & dosificación , Adenosina/farmacología , Adenosina/metabolismo , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Neuronas/fisiología , Masculino , Anestésicos por Inhalación/farmacología , Anestésicos por Inhalación/administración & dosificación , Temperatura Corporal/efectos de los fármacos , Temperatura Corporal/fisiología , Hipotermia/inducido químicamente , Hipotermia/metabolismo , Letargo/efectos de los fármacos , Ratones , Proteínas Proto-Oncogénicas c-fos/metabolismo
2.
PLoS One ; 10(8): e0136113, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26295351

RESUMEN

BACKGROUND: Therapeutic hypothermia is used to reduce ischemia/reperfusion injury (IRI) during organ transplantation and major surgery, but does not fully prevent organ injury. Interestingly, hibernating animals undergo repetitive periods of low body temperature called 'torpor' without signs of organ injury. Recently, we identified an essential role of hydrogen sulfide (H2S) in entrance into torpor and preservation of kidney integrity during hibernation. A torpor-like state can be induced pharmacologically by injecting 5'-Adenosine monophosphate (5'-AMP). The mechanism by which 5'-AMP leads to the induction of a torpor-like state, and the role of H2S herein, remains to be unraveled. Therefore, we investigated whether induction of a torpor-like state by 5-AMP depends on H2S production. METHODS: To study the role of H2S on the induction of torpor, amino-oxyacetic acid (AOAA), a non-specific inhibitor of H2S, was administered before injection with 5'-AMP to block endogenous H2S production in Syrian hamster. To assess the role of H2S on maintenance of torpor induced by 5'-AMP, additional animals were injected with AOAA during torpor. KEY RESULTS: During the torpor-like state induced by 5'-AMP, the expression of H2S- synthesizing enzymes in the kidneys and plasma levels of H2S were increased. Blockade of these enzymes inhibited the rise in the plasma level of H2S, but neither precluded torpor nor induced arousal. Remarkably, blockade of endogenous H2S production was associated with increased renal injury. CONCLUSIONS: Induction of a torpor-like state by 5'-AMP does not depend on H2S, although production of H2S seems to attenuate renal injury. Unraveling the mechanisms by which 5'-AMP reduces the metabolism without organ injury may allow optimization of current strategies to limit (hypothermic) IRI and improve outcome following organ transplantation, major cardiac and brain surgery.


Asunto(s)
Adenosina Monofosfato/farmacología , Sulfuro de Hidrógeno/metabolismo , Letargo , Adenosina Monofosfato/administración & dosificación , Adenosina Monofosfato/metabolismo , Ácido Aminooxiacético/farmacología , Animales , Creatina/sangre , Creatina/metabolismo , Cricetinae , Sulfuro de Hidrógeno/antagonistas & inhibidores , Sulfuro de Hidrógeno/sangre , Hipotermia Inducida , Riñón/efectos de los fármacos , Riñón/metabolismo , Riñón/patología , Masculino , Mesocricetus , Letargo/efectos de los fármacos
3.
Diabetologia ; 58(4): 819-27, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25563725

RESUMEN

AIMS/HYPOTHESIS: Nutrient overabundance and diminished physical activity underlie the epidemic of obesity and its consequences of insulin resistance and type 2 diabetes. These same phenomena, obesity and insulin resistance, are also observed in mammals as they ready themselves for the nutrient deprivation of winter, yet their plasma glucose does not rise. Given the role of silent information regulator 2 (Sir2) and its mammalian orthologue, Sirt1, in survival and life extension during energy deprivation, we hypothesised that enhancing its activity may reduce the insensible energy loss engendered by hyperglycaemia and glycosuria. METHODS: At 8 weeks of age, db/db and db/m mice were randomised to receive the SIRT1 activator SRT3025 milled in chow (3.18 g/kg) or regular chow and followed for a further 12 weeks. RESULTS: When compared with vehicle, SIRT1 activation greatly improved glycaemic control, augmented plasma insulin concentrations, increased pancreatic islet beta cell mass and elevated hepatic expression of the beta cell growth factor, betatrophin in db/db mice. Despite the dramatic reduction in hyperglycaemia, db/db mice displayed worsening insulin resistance, diminished physical activity and further weight gain. These findings along with reduced food intake and reduction in body temperature resembled torpor and hibernation. By contrast, SIRT1 activation conferred only minimal changes in non-diabetic db/m mice. CONCLUSIONS/INTERPRETATION: While reducing hyperglycaemia and promoting beta cell expansion, enhancing the activity of SIRT1 facilitates a phenotypic change in a db/db mouse model of diabetes to one that more closely resembles the physiological state of torpor or hibernation.


Asunto(s)
Anilidas/farmacología , Glucemia/efectos de los fármacos , Diabetes Mellitus Tipo 2/prevención & control , Activadores de Enzimas/farmacología , Hipoglucemiantes/farmacología , Obesidad/tratamiento farmacológico , Sirtuina 1/metabolismo , Tiazoles/farmacología , Letargo/efectos de los fármacos , Proteína 8 Similar a la Angiopoyetina , Proteínas Similares a la Angiopoyetina , Animales , Glucemia/metabolismo , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/enzimología , Diabetes Mellitus Tipo 2/genética , Diabetes Mellitus Tipo 2/fisiopatología , Modelos Animales de Enfermedad , Activación Enzimática , Hepatocitos/efectos de los fármacos , Hepatocitos/metabolismo , Insulina/sangre , Resistencia a la Insulina , Células Secretoras de Insulina/efectos de los fármacos , Células Secretoras de Insulina/metabolismo , Masculino , Ratones Mutantes , Obesidad/sangre , Obesidad/enzimología , Obesidad/genética , Obesidad/fisiopatología , Hormonas Peptídicas/metabolismo , Transducción de Señal/efectos de los fármacos , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA